Status:
COMPLETED
Beta-Blocker Heart Attack Trial (BHAT)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arrhythmia
Cardiovascular Diseases
Eligibility:
All Genders
30-69 years
Phase:
PHASE3
Brief Summary
To determine whether the regular administration of the beta-blocker drug propranolol to people who had had at least one documented myocardial infarction would result in a significant reduction of mort...
Detailed Description
BACKGROUND: Survivors of a documented myocardial infarction are recognized as having a high risk of dying relative to the general population. Serious arrhythmias, occurring with or without evidence o...
Eligibility Criteria
Men and women, ages 30 to 69. Documented myocardial infarction.
Key Trial Info
Start Date :
September 1 1977
Trial Type :
INTERVENTIONAL
End Date :
October 1 1981
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000492
Start Date
September 1 1977
End Date
October 1 1981
Last Update
July 12 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.